Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System
- PMID: 24951868
- PMCID: PMC5946322
- DOI: 10.1016/j.vaccine.2014.06.034
Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System
Abstract
Background: The Vaccine Adverse Event Reporting System (VAERS) is a passive reporting system, used for monitoring the safety of all US licensed vaccines. In March 2008, ACAM2000(®) replaced Dryvax(®) as the only licensed smallpox vaccine and is administered to all persons entering military service and certain civilian researchers. In 2011, routine data mining of VAERS identified a vaccine safety concern resulting in acute ischemic cardiac events (ICE) following ACAM2000(®).
Methods: During March 1, 2008 through June 30, 2013, we reviewed all serious reports received following ACAM2000(®)and classified them by diagnostic category. We identified possible ICE cases by searching the Medical Dictionary for Regulatory Affairs (MedDRA(®)) terms for "myocardial ischaemia," "acute myocardial infarction," "myocardial infarction," and "ischaemia," and applied standardized surveillance case definitions.
Results: VAERS received 1149 reports following ACAM2000(®) administration; 169 (14.7%) were serious (resulting in permanent disability, hospitalization or prolongation of hospitalization, life-threatening illness or death), including one death. The two most frequent diagnostic categories for serious reports were cardiovascular and other infectious conditions. The MedDRA(®) search found 31 reports of possible ICE after receipt of ACAM2000(®) vaccine. Of a total 30 possible ICE cases with demographic information, all but one was male; the age range was 20-45 years (median 32) and median interval to onset of symptoms was 12 days. On clinical review there were 16 cases of myocarditis/pericarditis and 15 ICE cases.
Conclusions: Our review of the data mining signal did not substantiate the concerns about ICE after ACAM2000(®). Our study also suggests that with current pre-vaccination screening, cardiac morbidity in generally healthy vaccinated populations remains uncommon.
Keywords: ACAM2000(®); Ischemic cardiac events; Myo/pericarditis; Myocarditis; Pericarditis.
Published by Elsevier Ltd.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5946322/bin/nihms731972f1.gif)
Similar articles
-
Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.Vaccine. 2021 Sep 15;39(39):5541-5547. doi: 10.1016/j.vaccine.2021.08.041. Epub 2021 Aug 26. Vaccine. 2021. PMID: 34454787
-
Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).Hum Vaccin Immunother. 2013 Jul;9(7):1489-96. doi: 10.4161/hv.24319. Epub 2013 Apr 9. Hum Vaccin Immunother. 2013. PMID: 23571177 Free PMC article. Review.
-
Update: cardiac-related events during the civilian smallpox vaccination program--United States, 2003.MMWR Morb Mortal Wkly Rep. 2003 May 30;52(21):492-6. MMWR Morb Mortal Wkly Rep. 2003. PMID: 12809110
-
Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel.Vaccine. 2020 Oct 27;38(46):7323-7330. doi: 10.1016/j.vaccine.2020.09.037. Epub 2020 Sep 20. Vaccine. 2020. PMID: 32967791
-
ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Drug Des Devel Ther. 2010 May 25;4:71-9. doi: 10.2147/dddt.s3687. Drug Des Devel Ther. 2010. PMID: 20531961 Free PMC article. Review.
Cited by
-
Building a next-generation, two-component protein subunit vaccine against monkeypox virus.Nat Immunol. 2024 Feb;25(2):200-201. doi: 10.1038/s41590-023-01735-3. Nat Immunol. 2024. PMID: 38238610 No abstract available.
-
Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks.Viruses. 2023 Jul 12;15(7):1533. doi: 10.3390/v15071533. Viruses. 2023. PMID: 37515218 Free PMC article. Review.
-
Myocarditis in a young male affected with monkeypox infection: a case report.Eur Heart J Case Rep. 2023 Apr 25;7(5):ytad211. doi: 10.1093/ehjcr/ytad211. eCollection 2023 May. Eur Heart J Case Rep. 2023. PMID: 37181474 Free PMC article.
-
Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease.BMC Infect Dis. 2022 Dec 12;22(1):928. doi: 10.1186/s12879-022-07900-7. BMC Infect Dis. 2022. PMID: 36503476 Free PMC article. Review.
-
Monkeypox: epidemiology, pathogenesis, treatment and prevention.Signal Transduct Target Ther. 2022 Nov 2;7(1):373. doi: 10.1038/s41392-022-01215-4. Signal Transduct Target Ther. 2022. PMID: 36319633 Free PMC article. Review.
References
-
- Rotz L, Dotson DA, Damon IK, Becher JA. Vaccinia (Smallpox) Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR. 2001;50(RR-10):1–26. - PubMed
-
- Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA. 2003;289:3278–3282. - PubMed
-
- Department of Health and Human Services. Declaration regarding administration of smallpox countermeasures. [accessed August 5, 2013];Federal Register. 2003 68:4212–3. Available at: http://www.gpo.gov/fdsys/pkg/FR-2003-01-28/pdf/03-2012.pdf#page=1.
-
- Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC) MMWR Recom Rep. 2003;52(RR-1):1–16. - PubMed
-
- Casey CG, Iskander J, Roper MH, Mast EE, Wen XJ, Torok TJ, et al. Adverse events associated with smallpox vaccination in the United States, January–October 2003. JAMA. 2005;294:2734–43. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical